Is Inovio Pharmaceuticals a Buy?

To say that Inovio Pharmaceuticals (NASDAQ: INO) is a volatile stock would be an understatement. In the past year, its share price has risen to highs of more than $30, and it has also hit lows of just over $3. Depending on when you bought and sold the stock, it could have easily made you rich or destroyed your portfolio.

Today, it's still in the COVID-19 vaccine race even though it's trailing the big leaders, Moderna and Pfizer. But is hope for its vaccine candidate, INO-4800, worth investing in Inovio? Or is there simply too much risk given the lack of other products to fall back on if it fails? Let's take a closer look at the company's business, its latest developments, and whether this stock, which has fallen 60% in the past six months (while the S&P 500 has risen 17%) is a good buy today.

Image source: Getty Images.

Source Fool.com